Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | STRO-002 |
Trade Name | |
Synonyms | STRO002 |
Drug Descriptions |
STRO-002 is an antibody-drug conjugate (ADC) that consists of an anti-FolRa human IgG1 antibody linked to the anti-tubulin agent 3-aminophenyl hemiasterlin (SC209), which potentially inhibits growth of FolRa-expressing tumors (PMID: 36459691). |
DrugClasses | FOLR1-targeted Therapy 17 |
CAS Registry Number | NA |
NCIT ID | C158067 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bevacizumab + STRO-002 | Bevacizumab STRO-002 | 0 | 1 |
Carboplatin + STRO-002 | Carboplatin STRO-002 | 0 | 0 |
STRO-002 | STRO-002 | 0 | 1 |